TrialInternational journal of clinical oncology2020

Low incidence of late recurrence in patients with intermediate-risk prostate cancer treated by intensity-modulated radiation therapy plus short-term androgen deprivation therapy.

Rihito Aizawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.